Viking Therapeutics (1VT) Q2 2026 Earnings Report
DE:1VT Q2 2026 EPS Results
- Actual EPS
- -EUR 0.98
- Consensus EPS
- -EUR 1.10
- Beat/Miss
- Beat by +EUR 0.12
- One Year Ago EPS
- -EUR 0.52
DE:1VT Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/29/2026
- Time
- After Close
- Conference Call
- Wednesday, July 29, 2026
DE:1VT Upcoming Earnings
Viking Therapeutics's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:1VT Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1VT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2026 (Q4) | -1.23- | -1.24 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | -0.95-1.39 | -0.73 | -91.36% (-0.66) | |
| Jul 29, 2026 | 2026 (Q2) | -1.10-0.98 | -0.52 | -89.66% (-0.47) | |
| Apr 29, 2026 | 2026 (Q1) | -0.87-1.23 | -0.37 | -234.15% (-0.86) | |
| Feb 11, 2026 | 2025 (Q4) | -0.80-1.24 | -0.29 | -331.25% (-0.95) | |
| Oct 22, 2025 | 2025 (Q3) | -0.64-0.73 | -0.2 | -268.18% (-0.53) | |
| Jul 24, 2025 | 2025 (Q2) | -0.40-0.52 | -0.18 | -190.00% (-0.34) | |
| Apr 23, 2025 | 2025 (Q1) | -0.29-0.37 | -0.23 | -57.69% (-0.13) | |
| Feb 05, 2025 | 2024 (Q4) | -0.25-0.29 | -0.22 | -28.00% (-0.06) | |
| Oct 23, 2024 | 2024 (Q3) | -0.22-0.20 | -0.21 | 4.35% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
